These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3081995)

  • 1. A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
    Fuse I; Hattori A; Higashihara M; Takizawa S; Takeshige T; Hanano M; Nagayama R; Koike T; Takahashi H; Shibata A
    Scand J Haematol; 1986 Jan; 36(1):44-54. PubMed ID: 3081995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
    Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
    Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol esters and oleoyl acetoyl glycerol enhance release of arachidonic acid in platelets stimulated by Ca2+ ionophore A23187.
    Halenda SP; Zavoico GB; Feinstein MB
    J Biol Chem; 1985 Oct; 260(23):12484-91. PubMed ID: 3930496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the mode of action of 1-oleoyl-2-acetyl-glycerol and phorbol ester in platelet activation.
    Ashby B; Kowalska MA; Wernick E; Rigmaiden M; Daniel JL; Smith JB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):473-83. PubMed ID: 2999204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tetradecanoylphorbol acetate on calcium-ion mobilization, protein phosphorylation and cytoskeletal assembly induced by thrombin or arachidonate.
    Cox AC; Carroll RC
    Biochim Biophys Acta; 1986 May; 886(3):390-8. PubMed ID: 3085729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
    Kornecki E; Ehrlich YH; Lenox RH
    Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type.
    Krishnamurthi S; Joseph S; Kakkar VV
    Eur J Biochem; 1987 Sep; 167(3):585-93. PubMed ID: 3653105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
    Steiner M; Landolfi R; Motola NC; Turcotte JG
    Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphorylation and diglyceride production during serotonin release induced by epinephrine plus ADP in human platelets.
    Kawahara Y; Yamanishi J; Tsunemitsu M; Fukuzaki H
    Thromb Res; 1983 Jun; 30(5):477-85. PubMed ID: 6612681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA; Johnson PC; Smith M; Salzman EW
    Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.